Related Experiment Video
Updated: Mar 8, 2026

08:01
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
5.8K
Big and disparate data: considerations for pediatric consortia
Jeanette A Stingone1, Nancy Mervish, Patricia Kovatch
1aIcahn School of Medicine at Mount Sinai, New York, NY bRenssealear Polytechnic Institute, Troy, NY, USA.
Current Opinion in Pediatrics
|January 31, 2017
Summary
Children's health research consortia offer valuable big data for studying disease determinants. Addressing participation challenges is key to unlocking their full potential for groundbreaking pediatric research.
Area of Science:
- Pediatric epidemiology
- Big data in health research
- Children's health consortia
Background:
- Growing need to analyze large, diverse datasets for pediatric disease and disability.
- Children's health research consortia are crucial sources of big data.
- Understanding challenges and opportunities in pediatric big data research is essential.
Purpose of the Study:
- Review existing children's health consortia.
- Highlight pooled analyses from these consortia.
- Provide recommendations to advance collective pediatric research efforts.
Main Methods:
- Review of existing children's health research consortia.
- Analysis of recent pooled analyses from consortia.
- Identification of common challenges in pooled analyses.
Main Results:
- Formal consortia facilitate data sharing from multiple epidemiological studies.
- Collective efforts can achieve more than individual research groups.
- Practical challenges hinder investigator participation in consortia.
Conclusions:
- Accessing consortia data centers enables research beyond initial hypotheses.
- Consortia can facilitate previously infeasible or costly research.
- Addressing participation challenges is vital for consortium success.
Related Concept Videos
Data Collection III
4.8K
The physical assessment examines the patient for objective data that defines the patient's condition, and aids in formulating the nursing care plan. The purpose of physical assessment is a health status appraisal, which includes identifying health problems, and establishing a database for nursing intervention.
The principles to begin the physical assessment include conducting a comprehensive or problem-related history in a quiet, well-lit room, emphasizing privacy and comfort for the...
The principles to begin the physical assessment include conducting a comprehensive or problem-related history in a quiet, well-lit room, emphasizing privacy and comfort for the...
4.8K
Data Collection I
8.8K
Data collection gathers information needed to make accurate judgments about a patient's present condition. During a health history interview, subjective data is collected from the patient, their caregivers, or family members, and objective data is collected through observations and physical assessment. Patients are the primary source of subjective data. Thus information gathered from patients through interviews, observations, and physical examination is primary data. Secondary sources of...
8.8K
Analysis of Population Pharmacokinetic Data
886
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
886
Pharmacokinetics in Pediatric Patients: Drug Distribution
405
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405

